These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29618721)

  • 1. Risk of thrombosis and mortality in inflammatory bowel disease.
    Andrade AR; Barros LL; Azevedo MFC; Carlos AS; Damião AOMC; Sipahi AM; Leite AZA
    Clin Transl Gastroenterol; 2018 Apr; 9(4):142. PubMed ID: 29618721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors.
    Scoville EA; Konijeti GG; Nguyen DD; Sauk J; Yajnik V; Ananthakrishnan AN
    Inflamm Bowel Dis; 2014 Apr; 20(4):631-6. PubMed ID: 24552828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
    Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
    J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
    Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
    World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States.
    Tinsley A; Naymagon S; Trindade AJ; Sachar DB; Sands BE; Ullman TA
    J Clin Gastroenterol; 2013 Jan; 47(1):e1-6. PubMed ID: 22476043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic complications in inflammatory bowel diseases.
    Fornaro R; Caristo G; Stratta E; Caratto M; Caratto E; Giovinazzo D; Di Maira L; Casaccia M; Frascio M
    G Chir; 2019; 40(1):14-19. PubMed ID: 30771793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare.
    Sbeit W; Kadah A; Shafrir A; Kalisky I; Mahamid M; Hazou W; Katz L; Mari A; Khoury T
    Minerva Med; 2020 Dec; 111(6):560-565. PubMed ID: 32729705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of venous thromboembolism prophylaxis during inflammatory bowel disease flares in the outpatient setting: a decision analysis.
    Nguyen GC; Sharma S
    Inflamm Bowel Dis; 2013 Sep; 19(10):2182-9. PubMed ID: 23883960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk of thromboembolic phenomena in patients with inflammatory bowel disease].
    Suárez Ferrer C; Vera Mendoza MI; Amo San Román L; González Lama Y; Calvo Moya M; García Casas M; Abreu García L
    Gastroenterol Hepatol; 2012 Nov; 35(9):634-9. PubMed ID: 23036695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    McCurdy JD; Kuenzig ME; Smith G; Spruin S; Murthy SK; Carrier M; Nguyen GC; Benchimol EI
    Inflamm Bowel Dis; 2020 Oct; 26(11):1761-1768. PubMed ID: 31995204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?
    Bryant RV; Jairath V; Curry N; Travis SP
    J Crohns Colitis; 2014 Feb; 8(2):166-71. PubMed ID: 24095288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case-control study in Canada.
    Ding Z; Sherlock M; Chan AKC; Zachos M
    Blood Coagul Fibrinolysis; 2022 Dec; 33(8):449-456. PubMed ID: 36409922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral venous thrombosis in inflammatory bowel diseases: eight cases and literature review.
    Cognat E; Crassard I; Denier C; Vahedi K; Bousser MG
    Int J Stroke; 2011 Dec; 6(6):487-92. PubMed ID: 22017824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
    Dwyer JP; Javed A; Hair CS; Moore GT
    Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Venous Thromboembolism Chemoprophylaxis Practices After Surgery for Inflammatory Bowel Diseases.
    Bickston SJ; Patrone MV
    Inflamm Bowel Dis; 2022 Aug; 28(8):1296-1297. PubMed ID: 35452122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.
    Ra G; Thanabalan R; Ratneswaran S; Nguyen GC
    J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of pharmacological prophylaxis against venous thromboembolism in hospitalised patients with severe active ulcerative colitis.
    Pleet JL; Vaughn BP; Morris JA; Moss AC; Cheifetz AS
    Aliment Pharmacol Ther; 2014 May; 39(9):940-8. PubMed ID: 24605866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.